First Tracks Biotherapeutics to Announce Phase 1b Trial Data on Oct. 12
First Tracks Biotherapeutics said it will review top-line data from Cohort 1 of its Phase 1b ANB033 trial in celiac disease during an investor call and webcast on Oct. 12, 2026.
First Tracks Biotherapeutics said it will review top-line data from Cohort 1 of its Phase 1b ANB033 trial in celiac disease during an investor call and webcast on Oct. 12, 2026.